SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 61 filers reported holding SUTRO BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $12,060,000 | +159.0% | 1,200,000 | +100.0% | 0.32% | +19.5% |
| Q2 2020 | $4,656,000 | -23.9% | 600,000 | 0.0% | 0.27% | -27.1% |
| Q1 2020 | $6,120,000 | -7.3% | 600,000 | 0.0% | 0.36% | +8.6% |
| Q4 2019 | $6,600,000 | +21.0% | 600,000 | 0.0% | 0.34% | +17.1% |
| Q3 2019 | $5,454,000 | -20.1% | 600,000 | 0.0% | 0.29% | -9.7% |
| Q2 2019 | $6,828,000 | -0.1% | 600,000 | 0.0% | 0.32% | -6.7% |
| Q1 2019 | $6,834,000 | +26.3% | 600,000 | 0.0% | 0.34% | +32.7% |
| Q4 2018 | $5,412,000 | -39.9% | 600,000 | 0.0% | 0.26% | -33.2% |
| Q3 2018 | $9,000,000 | – | 600,000 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |